Screener
Regeneron Pharmaceuticals REGN Raw materials
Raw materials at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's raw materials?
- Regeneron Pharmaceuticals (REGN) reported raw materials of $610.9M in Q2 2026.
- How has Regeneron Pharmaceuticals's raw materials changed year-over-year?
- Regeneron Pharmaceuticals's raw materials decreased by 18.8% year-over-year, from $752.3M to $610.9M.
- What is the long-term trend for Regeneron Pharmaceuticals's raw materials?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's raw materials has grown at a 6.9% compound annual growth rate (CAGR), from $459.4M to $641.5M.
- What does raw materials mean?
- Unprocessed materials and components purchased for use in manufacturing, valued at cost.
Ask your AI about Regeneron Pharmaceuticals's raw materials.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude